Skip to main content
    C

    Cardio Diagnostics Holdings Inc (CDIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.79
    -0.10 (-5.29%)

    Market Cap: $5.59M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Cardio Diagnostics Holdings Inc (CDIO) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Cardio Diagnostics Holdings are Cadrenal Therapeutics, Inc. Common Stock (CVKD), Biocardia (BCDA) and SeaStar Medical Holding (ICU). By market cap, Cardio Diagnostics Holdings ranks 5th of the 13 companies on this page; Biocardia (BCDA) is the largest at $12.58M.

    Peer Comparison

    CDIO's revenue growth of 25.7% is above the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Cardio Diagnostics Holdings (CDIO)$5.59MN/A348.9x0.0%N/A25.7%0.00%
    Cadrenal Therapeutics, Inc. Common Stock (CVKD)$5.39MN/AN/A0.0%N/A0.0%0.00%
    Biocardia Inc (BCDA)$12.58MN/AN/A0.0%N/A-100.0%0.00%
    SeaStar Medical Holding Corporation (ICU)$4.46MN/A1.7x0.0%N/A82.0%0.00%
    Kiora Pharmaceuticals Inc (KPRX)$5.44MN/A6.2x0.0%N/A0.0%0.00%
    PharmaCyte Biotech Inc (PMCB)$3.77MN/AN/A0.0%N/A0.0%0.00%
    Creative Medical Technology Holdings Inc (CELZ)$4.01MN/AN/A0.0%N/A0.0%0.00%
    FibroBiologics, Inc. Common Stock (FBLG)$6.57MN/AN/A0.0%N/A0.0%0.00%
    CytoMed Therapeutics Limited Ordinary Shares (GDTC)$9.90MN/A16.4x0.0%-72.3%-15.9%0.00%
    Imunon Inc (IMNN)$4.08MN/AN/A0.0%-131.5%0.0%0.00%
    Senti Biosciences Inc (SNTI)$5.38MN/A57.2x0.0%1039.8%-100.0%0.00%
    Phio Pharmaceuticals Corp (PHIO)$9.21MN/AN/A0.0%N/A0.0%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    Peer median$5.39MN/A11.3x0.0%-72.3%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Cardio Diagnostics Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Cadrenal Therapeutics, Inc. Common Stock (CVKD)
    Cadrenal Therapeutics, Inc. (CVKD) is a clinical-stage biopharmaceutical firm dedicated to developing groundbreaking therapies for renal diseases and associated...
    CVKD competitors
    Biocardia Inc (BCDA)
    BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease.
    BCDA competitors
    SeaStar Medical Holding Corporation (ICU)
    SeaStar Medical Holding Corporation (ICU) is a forward-looking biotechnology company dedicated to innovating treatment solutions for chronic kidney disease via...
    ICU competitors
    Kiora Pharmaceuticals Inc (KPRX)
    Kiora Pharmaceuticals Inc. is a clinical-stage biotechnology firm focused on developing innovative therapies for ocular diseases and neurodegenerative...
    KPRX competitors
    PharmaCyte Biotech Inc (PMCB)
    PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United...
    PMCB competitors
    Creative Medical Technology Holdings Inc (CELZ)
    Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics...
    CELZ competitors
    FibroBiologics, Inc. Common Stock (FBLG)
    FibroBiologics, Inc. is an innovative biotechnology company dedicated to advancing regenerative medicine through its proprietary fibroblast cell technology...
    FBLG competitors
    CytoMed Therapeutics Limited Ordinary Shares (GDTC)
    CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human...
    Imunon Inc (IMNN)
    Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious...
    IMNN competitors
    Senti Biosciences Inc (SNTI)
    Senti Biosciences Inc (SNTI) is a leading biotechnology firm specializing in synthetic biology...
    SNTI competitors
    Phio Pharmaceuticals Corp (PHIO)
    Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts.
    PHIO competitors
    CNS Pharmaceuticals Inc (CNSP)
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors

    Frequently Asked Questions About CDIO

    Who are Cardio Diagnostics Holdings' main competitors?

    The companies most similar to Cardio Diagnostics Holdings include Cadrenal Therapeutics, Inc. Common Stock (CVKD), Biocardia (BCDA), SeaStar Medical Holding (ICU), Kiora Pharmaceuticals (KPRX) and PharmaCyte Biotech (PMCB), listed from the closest match.

    Who is Cardio Diagnostics Holdings' biggest competitor?

    Biocardia (BCDA) is the largest of the similar companies at $12.58M; Cadrenal Therapeutics, Inc. Common Stock (CVKD) is the closest match by business profile, size, sector and industry.

    How does CDIO stock compare with its competitors?

    CDIO's P/S is 348.9x against a peer median of 11.3x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Cardio Diagnostics Holdings' competitors pays a higher dividend?

    Cardio Diagnostics Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Cardio Diagnostics Holdings bigger than its competitors?

    No. Cardio Diagnostics Holdings is 5th by market cap among the 13 companies on this page; the largest is Biocardia (BCDA) at $12.58M.